3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice

Alexander C. Langheinrich, Daniel G. Sedding, Marian Kampschulte, Regina Moritz, Jochen Wilhelm, Werner G. Haberbosch, Erik L. Ritman, Rainer M. Bohle

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Atherosclerosis and inflammation/angiogenesis are strongly associated including growth of vasa vasorum (VV) and plaque neovascularization, but a causative role for neovascularization has still not been established. Hence, we investigated the effect of 3-deazaadenosine (c3Ado), an anti-inflammatory and anti-proliferative drug, on plaque progression and VV neovascularization in apoE-/-/LDL-/- double knockout mice. Methods: The arterial trees from apoE-/-/LDL-/- mice with, or without c3Ado at the age of 16 weeks (n = 10), 18 weeks (n = 8) and 20 weeks (n = 7) were infused in situ with Microfil, and the aortas harvested and scanned with micro-CT (12 μm cubic voxel). We characterized plaque volume and VV luminal volume along the descending aorta using Analyze 6.0 software. Cellular effects of c3Ado on human endothelial and vascular smooth muscle cells were investigated in cell cultures and on nylon cDNA expression arrays. Results: Lesions spatially connected to VV increased from 16 to 20 weeks significantly (p < 0.001). The volume of atherosclerotic lesions was significantly reduced in animals treated with c3Ado (p < 0.01). This was accompanied by a significant decrease of vasa vasorum neovascularization along the descending aorta (p < 0.01). Using nylon cDNA expression arrays, we identified the regulation of anti-proliferative, anti-inflammatory genes in human smooth muscle cells which might be involved in the anti-angiogenic effects of c3Ado. Moreover, c3Ado dose-dependently prevented the proliferation and migration of human coronary artery endothelial cells in vitro. Conclusion: The smaller lesion volume in animals treated with c3Ado was closely associated with a reduced VV neovascularization, suggesting a direct relationship between lesion growth and VV development.

Original languageEnglish (US)
Pages (from-to)103-110
Number of pages8
JournalAtherosclerosis
Volume202
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Vasa Vasorum
Apolipoproteins E
Knockout Mice
Aorta
Nylons
Oligonucleotide Array Sequence Analysis
Thoracic Aorta
Smooth Muscle Myocytes
Anti-Inflammatory Agents
Silicone Elastomers
Growth
3-deazaadenosine
oxidized low density lipoprotein
Vascular Smooth Muscle
Atherosclerosis
Coronary Vessels
Software
Endothelial Cells
Cell Culture Techniques
Inflammation

Keywords

  • 3-Deazaadenosine
  • Angiogenesis
  • Atherosclerosis
  • Micro-CT
  • Vasa vasorum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Langheinrich, A. C., Sedding, D. G., Kampschulte, M., Moritz, R., Wilhelm, J., Haberbosch, W. G., ... Bohle, R. M. (2009). 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice. Atherosclerosis, 202(1), 103-110. https://doi.org/10.1016/j.atherosclerosis.2008.04.008

3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice. / Langheinrich, Alexander C.; Sedding, Daniel G.; Kampschulte, Marian; Moritz, Regina; Wilhelm, Jochen; Haberbosch, Werner G.; Ritman, Erik L.; Bohle, Rainer M.

In: Atherosclerosis, Vol. 202, No. 1, 01.2009, p. 103-110.

Research output: Contribution to journalArticle

Langheinrich, AC, Sedding, DG, Kampschulte, M, Moritz, R, Wilhelm, J, Haberbosch, WG, Ritman, EL & Bohle, RM 2009, '3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice', Atherosclerosis, vol. 202, no. 1, pp. 103-110. https://doi.org/10.1016/j.atherosclerosis.2008.04.008
Langheinrich, Alexander C. ; Sedding, Daniel G. ; Kampschulte, Marian ; Moritz, Regina ; Wilhelm, Jochen ; Haberbosch, Werner G. ; Ritman, Erik L. ; Bohle, Rainer M. / 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice. In: Atherosclerosis. 2009 ; Vol. 202, No. 1. pp. 103-110.
@article{a17c04e300bb47279171023723a3ddd2,
title = "3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice",
abstract = "Background: Atherosclerosis and inflammation/angiogenesis are strongly associated including growth of vasa vasorum (VV) and plaque neovascularization, but a causative role for neovascularization has still not been established. Hence, we investigated the effect of 3-deazaadenosine (c3Ado), an anti-inflammatory and anti-proliferative drug, on plaque progression and VV neovascularization in apoE-/-/LDL-/- double knockout mice. Methods: The arterial trees from apoE-/-/LDL-/- mice with, or without c3Ado at the age of 16 weeks (n = 10), 18 weeks (n = 8) and 20 weeks (n = 7) were infused in situ with Microfil, and the aortas harvested and scanned with micro-CT (12 μm cubic voxel). We characterized plaque volume and VV luminal volume along the descending aorta using Analyze 6.0 software. Cellular effects of c3Ado on human endothelial and vascular smooth muscle cells were investigated in cell cultures and on nylon cDNA expression arrays. Results: Lesions spatially connected to VV increased from 16 to 20 weeks significantly (p < 0.001). The volume of atherosclerotic lesions was significantly reduced in animals treated with c3Ado (p < 0.01). This was accompanied by a significant decrease of vasa vasorum neovascularization along the descending aorta (p < 0.01). Using nylon cDNA expression arrays, we identified the regulation of anti-proliferative, anti-inflammatory genes in human smooth muscle cells which might be involved in the anti-angiogenic effects of c3Ado. Moreover, c3Ado dose-dependently prevented the proliferation and migration of human coronary artery endothelial cells in vitro. Conclusion: The smaller lesion volume in animals treated with c3Ado was closely associated with a reduced VV neovascularization, suggesting a direct relationship between lesion growth and VV development.",
keywords = "3-Deazaadenosine, Angiogenesis, Atherosclerosis, Micro-CT, Vasa vasorum",
author = "Langheinrich, {Alexander C.} and Sedding, {Daniel G.} and Marian Kampschulte and Regina Moritz and Jochen Wilhelm and Haberbosch, {Werner G.} and Ritman, {Erik L.} and Bohle, {Rainer M.}",
year = "2009",
month = "1",
doi = "10.1016/j.atherosclerosis.2008.04.008",
language = "English (US)",
volume = "202",
pages = "103--110",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE-/-/LDL-/- double knockout mice

AU - Langheinrich, Alexander C.

AU - Sedding, Daniel G.

AU - Kampschulte, Marian

AU - Moritz, Regina

AU - Wilhelm, Jochen

AU - Haberbosch, Werner G.

AU - Ritman, Erik L.

AU - Bohle, Rainer M.

PY - 2009/1

Y1 - 2009/1

N2 - Background: Atherosclerosis and inflammation/angiogenesis are strongly associated including growth of vasa vasorum (VV) and plaque neovascularization, but a causative role for neovascularization has still not been established. Hence, we investigated the effect of 3-deazaadenosine (c3Ado), an anti-inflammatory and anti-proliferative drug, on plaque progression and VV neovascularization in apoE-/-/LDL-/- double knockout mice. Methods: The arterial trees from apoE-/-/LDL-/- mice with, or without c3Ado at the age of 16 weeks (n = 10), 18 weeks (n = 8) and 20 weeks (n = 7) were infused in situ with Microfil, and the aortas harvested and scanned with micro-CT (12 μm cubic voxel). We characterized plaque volume and VV luminal volume along the descending aorta using Analyze 6.0 software. Cellular effects of c3Ado on human endothelial and vascular smooth muscle cells were investigated in cell cultures and on nylon cDNA expression arrays. Results: Lesions spatially connected to VV increased from 16 to 20 weeks significantly (p < 0.001). The volume of atherosclerotic lesions was significantly reduced in animals treated with c3Ado (p < 0.01). This was accompanied by a significant decrease of vasa vasorum neovascularization along the descending aorta (p < 0.01). Using nylon cDNA expression arrays, we identified the regulation of anti-proliferative, anti-inflammatory genes in human smooth muscle cells which might be involved in the anti-angiogenic effects of c3Ado. Moreover, c3Ado dose-dependently prevented the proliferation and migration of human coronary artery endothelial cells in vitro. Conclusion: The smaller lesion volume in animals treated with c3Ado was closely associated with a reduced VV neovascularization, suggesting a direct relationship between lesion growth and VV development.

AB - Background: Atherosclerosis and inflammation/angiogenesis are strongly associated including growth of vasa vasorum (VV) and plaque neovascularization, but a causative role for neovascularization has still not been established. Hence, we investigated the effect of 3-deazaadenosine (c3Ado), an anti-inflammatory and anti-proliferative drug, on plaque progression and VV neovascularization in apoE-/-/LDL-/- double knockout mice. Methods: The arterial trees from apoE-/-/LDL-/- mice with, or without c3Ado at the age of 16 weeks (n = 10), 18 weeks (n = 8) and 20 weeks (n = 7) were infused in situ with Microfil, and the aortas harvested and scanned with micro-CT (12 μm cubic voxel). We characterized plaque volume and VV luminal volume along the descending aorta using Analyze 6.0 software. Cellular effects of c3Ado on human endothelial and vascular smooth muscle cells were investigated in cell cultures and on nylon cDNA expression arrays. Results: Lesions spatially connected to VV increased from 16 to 20 weeks significantly (p < 0.001). The volume of atherosclerotic lesions was significantly reduced in animals treated with c3Ado (p < 0.01). This was accompanied by a significant decrease of vasa vasorum neovascularization along the descending aorta (p < 0.01). Using nylon cDNA expression arrays, we identified the regulation of anti-proliferative, anti-inflammatory genes in human smooth muscle cells which might be involved in the anti-angiogenic effects of c3Ado. Moreover, c3Ado dose-dependently prevented the proliferation and migration of human coronary artery endothelial cells in vitro. Conclusion: The smaller lesion volume in animals treated with c3Ado was closely associated with a reduced VV neovascularization, suggesting a direct relationship between lesion growth and VV development.

KW - 3-Deazaadenosine

KW - Angiogenesis

KW - Atherosclerosis

KW - Micro-CT

KW - Vasa vasorum

UR - http://www.scopus.com/inward/record.url?scp=57649195270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649195270&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2008.04.008

DO - 10.1016/j.atherosclerosis.2008.04.008

M3 - Article

VL - 202

SP - 103

EP - 110

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -